iShares U.S. Pharmaceuticals ETF (IHE) Holdings $71.54 +0.42 (+0.59%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartHeadlinesHoldingsOwnership Top 45 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1LLYEli Lilly and Company$874.12+0.1%24.44%02JNJJohnson & Johnson$162.35+1.7%23.93%03PFEPfizer$26.32+1.6%4.53%04ITCIIntra-Cellular Therapies$128.60+0.0%4.42%05BMYBristol-Myers Squibb$55.85+0.1%4.41%06RPRXRoyalty Pharma$33.42+0.3%4.34%07ZTSZoetis$160.39+1.9%4.15%08MRKMerck & Co., Inc.$89.40+2.0%3.78%09VTRSViatris$11.25+1.7%3.78%010JAZZJazz Pharmaceuticals$136.01-0.5%2.90%0 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11CORTCorcept Therapeutics$63.54-2.4%2.40%012ELANElanco Animal Health$11.02-1.0%2.02%013AXSMAxsome Therapeutics$137.75+6.7%1.88%014PBHPrestige Consumer Healthcare$84.66-0.1%1.48%015OGNOrganon & Co.$15.47-1.4%1.47%016PRGOPerrigo$25.37+0.5%1.18%017SUPNSupernus Pharmaceuticals$33.05-4.5%0.76%018LGNDLigand Pharmaceuticals$120.56-1.2%0.75%019TARSTarsus Pharmaceuticals$47.84-1.8%0.64%020EWTXEdgewise Therapeutics$27.07-0.1%0.54%021HRMYHarmony Biosciences$34.56-0.9%0.52%022WVEWave Life Sciences$11.13-1.8%0.44%023PCRXPacira BioSciences$25.16-2.3%0.43%024AMPHAmphastar Pharmaceuticals$31.28-0.1%0.42%025AMRXAmneal Pharmaceuticals$7.83-0.5%0.41%026ARVNArvinas$17.77-3.3%0.40%027COLLCollegium Pharmaceutical$29.13-2.1%0.35%028INVAInnoviva$18.08+0.1%0.35%029ANIPANI Pharmaceuticals$57.94-2.9%0.34%030HROWHarrow$28.95-3.9%0.34%031OCULOcular Therapeutix$7.00-3.4%0.33%032LQDALiquidia$16.11-2.4%0.27%033EOLSEvolus$13.99-4.3%0.26%034ELVNEnliven Therapeutics$21.80+1.5%0.23%035MNMDMind Medicine (MindMed)$7.63-6.7%0.20%036NUVBNuvation Bio$2.21-2.9%0.20%037OMEROmeros$9.18-4.5%0.18%038TBPHTheravance Biopharma$9.31-3.6%0.12%039BLK CSH FND TREASURY SL AGENCYN/A0.10%040PHATPhathom Pharmaceuticals$5.67+2.3%0.09%0Alert: DOGE goes live (Ad)"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook.Click here to learn more.41USDProShares Ultra Semiconductors$62.81-7.4%0.09%042PLRXPliant Therapeutics$3.08+2.3%0.06%043NMRANeumora Therapeutics$1.80+5.3%0.05%044CASH COLLATERAL USD SGAFTN/A0.01%045E-MINI HEALTH CARE SECTOR MAR 25N/A0.00%0 Geographic ExposureUnited States95.0%Ireland4.1%Singapore0.5%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care91.0%Energy0.3%Industry ExposureBiotechnology80.4%Pharmaceuticals6.5%Renewable Energy0.3%Health Care Equipment & Supplies0.3%SubIndustry ExposureBiotechnology76.9%Pharmaceuticals8.5%Renewable Energy Equipment0.3%Health Care Supplies0.3%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies VanEck Pharmaceutical ETF Portfolio iShares U.S. Healthcare Providers ETF Portfolio Direxion Daily S&P Biotech Bull 3x Shares Portfolio VanEck Biotech ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio Invesco Pharmaceuticals ETF Portfolio Invesco Biotechnology & Genome ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio This page (NYSEARCA:IHE) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredWarning: China Launches AI Attack on AmericaIf you have any money in AI stocks, pay attention because... According to Louis Navellier, the legendary in...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
